See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 14, 2003

Ulcerative Colitis Lung Cancer Prostate Cancer

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Ulcerative Colitis

A study of an investigational medication for patients with mild to moderately active ulcerative colitis. Volunteers 18 years of age or older who are currently taking oral mesalamine (such as Asacol(tm), Pentasa(tm), or Colazal(tm)), 6-mercaptopurine (such as Purinethol(tm)) or azathioprine therapy (such as Imuran(tm)) may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat152.html.

-----

Lung Cancer

A study of a combination of medications in patients with advanced non-small cell lung cancer. Volunteers age 18 or older with histopathologically or cytologically proven non-small cell carcinoma of the lung, either Stage IIIB or Stage IV, that has progressed on or after platinum-based chemotherapy may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat34.html.

-----

Prostate Cancer

A study of an investigational medication for prostate cancer. Volunteers with histologically documented adenocarcinoma of the prostate whose cancer has progressed while on hormone therapy may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat36.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.